Rehmann Capital Advisory Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$19.3K Buy
1,089
+209
+24% +$4.23K ﹤0.01% 881
2019
Q2
$18.8K Sell
880
-1,558
-64% -$32.7K ﹤0.01% 1162
2019
Q1
$58K Buy
2,438
+1,702
+231% +$38.8K 0.01% 766
2018
Q4
$14.5K Buy
736
+230
+45% +$4.1K ﹤0.01% 945
2018
Q3
$8.97K Sell
506
-85
-14% -$1.66K ﹤0.01% 1401
2018
Q2
$12.7K Buy
591
+213
+56% +$4.41K ﹤0.01% 1258
2018
Q1
$8K Buy
+378
New +$10.4K ﹤0.01% 1377

Other funds holding EXEL

Rehmann Capital Advisory Group's EXEL Position: Q3 2019 in Review

Rehmann Capital Advisory Group increased its Exelixis (EXEL) stake by 24% in Q3 2019, buying an estimated $4.23K and bringing the position to 1,089 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Rehmann Capital Advisory Group first reported a position in EXEL in Q1 2018 and has held it in 7 quarters since. The position peaked at $58K in Q1 2019. 339 funds tracked by Wall St. Rank hold EXEL as of Q3 2019.

  • Rehmann Capital Advisory Group held 1,089 shares of Exelixis worth $19.3K as of Q3 2019.
  • Rehmann Capital Advisory Group bought 209 Exelixis shares in Q3 2019, an estimated $4.23K.
  • Exelixis made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #881 holding.
  • Rehmann Capital Advisory Group first reported a position in Exelixis in Q1 2018 and has held it in 7 quarters since.
  • Rehmann Capital Advisory Group's Exelixis position peaked at $58K in Q1 2019.
  • 339 funds tracked by Wall St. Rank held Exelixis as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.